General MedicationsORALGeneric

PENTOBARBITAL SODIUM

Standard Dose

50MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview PENTOBARBITAL SODIUM is listed in Drugs@FDA under application 085937 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PENTOBARBITAL SODIUM Form and strength CAPSULE;ORAL - 50MG Sponsor LANNETT Submission history Latest submission status date: 2019-02-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview PENTOBARBITAL SODIUM is listed in Drugs@FDA under application 085937 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PENTOBARBITAL SODIUM Form and strength CAPSULE;ORAL - 50MG Sponsor LANNETT Submission history Latest submission status date: 2019-02-06 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.